Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

12345678910...
CompanyDrug NameStatusIndication Group
GlaxoSmithKline Valtrex Approved in USAAnti-infectives for systemic use
GlaxoSmithKline VALTREX Approved in USAAnti-infectives for systemic use
GlaxoSmithKline VALTREX Approved in USAAnti-infectives for systemic use
Medarex Valortim accomplished Phase IAnti-infectives for systemic use
Roche Valcyte Approved in USAAnti-infectives for systemic use
IDM Pharma Uvidem in Phase IIAntineoplastic & immunomodulating agents
Sanofi-aventis Uroxatral Approved in EUGenito urinary system & sex hormones
Teva Pharmaceutical Uroflux accomplished Phase IIGenito urinary system & sex hormones
Idenix TYZEKA Approved in US and ChinaAnti-infectives for systemic use
Biogen Idec Tysabri Submitted for approval in EUAlimentary tract & metabolism
Biogen Idec Tysabri Approved in USA and EUNervous system
Biogen Idec Tysabri accomplished Phase IIMusculoskeletal system
GlaxoSmithKline Tykerb Approved in USA, submitted for approval in EUAntineoplastic & immunomodulating agents
Wyeth Tygacil Approved in EU and USAAnti-infectives for systemic use
Geron TVAX accomplished Phase IIAntineoplastic & immunomodulating agents
Gilead Sciences Truvada Approved in EU and USAAnti-infectives for systemic use
Genomix TROXATYL in Phase IIIAntineoplastic & immunomodulating agents
Cephalon Trisenox in Phase IIIAntineoplastic & immunomodulating agents
Cephalon Trisenox in Phase IAntineoplastic & immunomodulating agents
Cephalon Trisenox Approved in USAAntineoplastic & immunomodulating agents
12345678910...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.